CTI(SZ:300012) Xin Lang Cai Jing·2025-10-17 01:30Core Insights - Huace Testing's stock increased by 0.56% on October 16, with a trading volume of 920 million yuan, indicating active market participation [1] - The company reported a net financing outflow of 666.36 million yuan on the same day, with a total financing and margin balance of 702 million yuan [1] - As of June 30, Huace Testing achieved a revenue of 2.96 billion yuan for the first half of 2025, reflecting a year-on-year growth of 6.05%, and a net profit of 467 million yuan, up 7.03% [2] Financing and Margin Data - On October 16, Huace Testing had a financing buy-in of 86.64 million yuan, with a current financing balance of 682 million yuan, representing 2.84% of its market capitalization [1] - The company’s financing balance is above the 90th percentile of the past year, indicating a high level of leverage [1] - In terms of margin trading, 4,100 shares were repaid, with a short-selling amount of 34.65 million yuan, and a margin balance of 19.79 million yuan, also above the 90th percentile of the past year [1] Shareholder and Dividend Information - As of June 30, the number of Huace Testing shareholders increased to 81,100, a rise of 4.53%, while the average number of circulating shares per person decreased by 4.34% [2] - The company has distributed a total of 1.161 billion yuan in dividends since its A-share listing, with 519 million yuan distributed over the last three years [3] - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 269 million shares, an increase of 7.8679 million shares compared to the previous period [3]